Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer

AHSCX Fund  USD 13.51  0.09  0.67%   
Slightly above 52% of Alger Health's investor base is interested to short. The analysis of overall sentiment of trading Alger Health Sciences mutual fund suggests that many investors are impartial at this time. Alger Health's investing sentiment can be driven by a variety of factors including economic data, Alger Health's earnings reports, geopolitical events, and overall market trends.
  
Novartis has entered into an exclusive license and collaboration agreement with Ratio Therapeutics for the development of a SSTR2 radiotherapeutic candidate for cancer.

Read at seekingalpha.com
seekingalpha News
  

Alger Health Fundamental Analysis

We analyze Alger Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alger Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alger Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Three Year Return

Three Year Return Comparative Analysis

Alger Health is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.

Alger Health Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alger Health mutual fund to make a market-neutral strategy. Peer analysis of Alger Health could also be used in its relative valuation, which is a method of valuing Alger Health by comparing valuation metrics with similar companies.

Other Information on Investing in Alger Mutual Fund

Alger Health financial ratios help investors to determine whether Alger Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alger with respect to the benefits of owning Alger Health security.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges